NASDAQ:BSEM Biostem Technologies (BSEM) Stock Price, News & Analysis $0.82 +0.01 (+0.83%) As of 03:02 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsSEC Filings About Biostem Technologies Stock (NASDAQ:BSEM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Biostem Technologies alerts:Sign Up Key Stats Today's Range$0.83▼$0.9450-Day Range$0.82▼$4.7452-Week Range$0.81▼$8.40Volume222,740 shsAverage Volume114,986 shsMarket Capitalization$15.82 millionP/E RatioN/ADividend YieldN/APrice Target$9.00Consensus RatingHold Company Overview BioStem Technologies is a biotechnology company focused on developing and commercializing human placental tissue allografts for regenerative medicine. Its products are made from donated birth tissue and are intended for use by healthcare professionals in areas including wound care and surgical applications. The company’s portfolio includes products marketed under brands such as VENDAJE, Neox and Clarix. BioStem uses its BioRetain processing method to prepare placental tissue while retaining key characteristics of the original material. BioStem serves healthcare providers in the United States. Its business centers on supplying these tissue-based products for clinical use; the company’s product offerings and applications are subject to applicable regulatory requirements.AI Generated. May Contain Errors. Read More Biostem Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks72nd Percentile Overall ScoreBSEM MarketRank™: 3.575323790045 of 5 starsBiostem Technologies scored higher than 72% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingBiostem Technologies has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialBiostem Technologies has a consensus price target of $9.00, representing about 918.1% upside from its current price of $0.88.Amount of Analyst CoverageBiostem Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Biostem Technologies' stock forecast and price target. Earnings and Valuation1.4 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Biostem Technologies are expected to grow in the coming year, from ($1.90) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Biostem Technologies is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBiostem Technologies has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.54% of the float of Biostem Technologies has been sold short.Short Interest Ratio / Days to CoverBiostem Technologies has a short interest ratio ("days to cover") of 1.53, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Biostem Technologies has recently decreased by 14.05%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBiostem Technologies does not currently pay a dividend.Dividend GrowthBiostem Technologies does not have a long track record of dividend growth. News and Social Media1.6 / 5News Sentiment-0.51 News SentimentBiostem Technologies has a news sentiment score of -0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Biostem Technologies this week, compared to 2 articles on an average week.Search InterestOnly 26 people have searched for BSEM on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.MarketBeat Follows2 people have added Biostem Technologies to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Biostem Technologies insiders have not sold or bought any company stock.Percentage Held by InstitutionsBiostem Technologies has minimal institutional ownership at this time.Read more about Biostem Technologies' insider trading history. Receive BSEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biostem Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSEM Stock News HeadlinesBioStem Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 14, 2026 | marketscreener.comMBioStem (BSEM) Q3 2026 Earnings Call TranscriptNovember 13, 2026 | finance.yahoo.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 19 at 1:00 AM | Base Camp Trading (Ad)Transcript : BioStem Technologies, Inc., Q3 2026 Earnings Call, Nov 12, 2026November 12, 2026 | marketscreener.comMBiostem outlines $10M-$12M annual cash opex cuts as it targets in-house manufacturing in H1 2027November 12, 2026 | seekingalpha.comBioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of PortfolioNovember 12, 2026 | globenewswire.comBioStem Technologies (BSEM) AI Stock AnalysisNovember 3, 2026 | tipranks.comBioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026October 29, 2026 | globenewswire.comSee More Headlines BSEM Stock Analysis - Frequently Asked Questions How have BSEM shares performed this year? Biostem Technologies' stock was trading at $3.9090 on January 1st, 2026. Since then, BSEM shares have decreased by 77.4% and is now trading at $0.8840. How were Biostem Technologies' earnings last quarter? Biostem Technologies, Inc. (NASDAQ:BSEM) posted its quarterly earnings results on Thursday, November, 12th. The company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.21. The firm had revenue of $7.64 million for the quarter, compared to analysts' expectations of $7.17 million. Biostem Technologies had a negative trailing twelve-month return on equity of 116.63% and a negative net margin of 121.02%. Read the conference call transcript. How do I buy shares of Biostem Technologies? Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biostem Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biostem Technologies investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Tesla (TSLA), Broadcom (AVGO) and SoundHound AI (SOUN). Company Calendar Last Earnings11/12/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:BSEM Previous SymbolOTCMKTS:BSEM CIK1658678 WebN/A Phone(954) 380-8342FaxN/AEmployees2Year FoundedN/APrice Target and Rating Average Price Target for Biostem Technologies$9.00 High Price Target$9.00 Low Price Target$9.00 Potential Upside/Downside+996.2%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($2.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.58 million Net Margins-121.02% Pretax MarginN/A Return on Equity-116.63% Return on Assets-57.99% Debt Debt-to-Equity RatioN/A Current Ratio0.73 Quick Ratio0.44 Sales & Book Value Annual Sales$47.48 million Price / Sales0.33 Cash FlowN/A Price / Cash FlowN/A Book Value$0.96 per share Price / Book0.86Miscellaneous Outstanding Shares19,180,000Free FloatN/AMarket Cap$15.75 million OptionableN/A Beta0.36 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:BSEM) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | Sponsored“IMPERIUM”: The #1 investment of 2027Could a strange new bio-chip be the most transformative innovation in history? Elon Musk calls it "amazing." A...Banyan Hill Publishing | SponsoredMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biostem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biostem Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.